PHIO
Phio Pharmaceuticals Corp.
NASDAQ · Healthcare · Biotechnology · US
$1.09
−1.80%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 1.00x
- Price / sales
- —
- Price / cash flow
- -1.04x
Enterprise value
- Enterprise value
- -$333.2K
- EV / sales
- —
- EV / EBITDA
- 0.03x
- EV / EBIT
- 0.02x
- Market cap
- $12.7M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026